Bertrand Georges
Chief Tech/Sci/R&D Officer at ALTIMMUNE, INC.
Bertrand Georges active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALTIMMUNE, INC. | Chief Tech/Sci/R&D Officer | 01/03/2015 | - |
Career history of Bertrand Georges
Former positions of Bertrand Georges
| Companies | Position | Start | End |
|---|---|---|---|
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01/01/2004 | 01/03/2015 |
| Founder | 05/10/1992 | 01/03/2015 | |
Sedac Therapeutics SA
 Sedac Therapeutics SA Medical/Nursing ServicesHealth Services Sedac Therapeutics SA develops new peptide formulas synthetic products in the fields of diagnosis and vaccine immunotherapy. The company is headquartered in Lyon, France. | Corporate Officer/Principal | 01/01/1999 | 01/01/2003 |
Training of Bertrand Georges
| Pasteur Institute of Iran | Doctorate Degree |
Statistics
International
| United Kingdom | 2 |
| United States | 2 |
| France | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Health Services | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALTIMMUNE, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Health Technology |
Sedac Therapeutics SA
Sedac Therapeutics SA Medical/Nursing ServicesHealth Services Sedac Therapeutics SA develops new peptide formulas synthetic products in the fields of diagnosis and vaccine immunotherapy. The company is headquartered in Lyon, France. | Health Services |
- Stock Market
- Insiders
- Bertrand Georges
- Experience
